Arkolith/Insider Trading/PCRX/Form 4

Cross Shawn

Chief Financial OfficerPacira BioSciences, Inc. (PCRX) · full profile →Form 4 · filed Apr 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$303K
Net Open-Market Flow
-$303K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Option exercise(M)2K$16.45$25K107K
Apr 22, 2026Sell(S)2K$25.01$38K105K
Apr 21, 2026Option exercise(M)3K$16.45$47K108K
Apr 21, 2026Sell(S)3K$25.01$71K105K
Apr 20, 2026Option exercise(M)8K$16.45$127K113K
Apr 20, 2026Sell(S)8K$25.14$194K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 22, 2026Option exercise(M)2K—$0163K
Apr 21, 2026Option exercise(M)3K—$0164K
Apr 20, 2026Option exercise(M)8K—$0167K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-026669) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Pacira BioSciences, Inc.

Build

Ask your agent about PCRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-26-026669"
Ask your agent
Use Arkolith to summarize insider buying and selling at Pacira BioSciences, Inc.
over the last 90 days and cite the filings.